GeneDx Holdings Corp. (WGS)

GeneDx Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	302.16	195.65	227.33	205.1	175.35
Other Revenue	3.29	6.91	7.36	7.1	3.97
Revenue	305.45	202.57	234.69	212.2	179.32
Revenue Growth (YoY)	50.79%	-13.69%	10.60%	18.33%	-8.59%
Cost of Revenue	111	116.06	259.52	228.8	155.73
Gross Profit	194.45	86.51	-24.82	-16.6	23.6
Selling, General & Admin	166.93	191.49	338.24	324.39	173.32
Research & Development	45.57	55.09	86.2	105.16	72.7
Other Operating Expenses	3.41	5.27	6.31	-	-
Operating Expenses	215.91	251.85	430.76	429.55	246.02
Operating Income	-21.46	-165.34	-455.58	-446.15	-222.42
Interest Expense	-3.03	-	-0.67	-2.84	-2.47
Interest & Investment Income	-	1.11	-	0.08	0.51
Other Non Operating Income (Expenses)	-13.6	2.17	60.09	198.22	0.02
EBT Excluding Unusual Items	-38.09	-162.06	-396.16	-250.69	-224.37
Merger & Restructuring Charges	-1.75	-6.53	-1.93	-	-
Gain (Loss) on Sale of Assets	-	1.68	-	-	-
Asset Writedown	-	-10.4	-210.15	-	-
Legal Settlements	-12.79	-1.13	-	-	-
Other Unusual Items	-	1.75	10.2	5.3	-16.97
Pretax Income	-52.63	-176.69	-598.03	-245.39	-241.34
Income Tax Expense	-0.34	-0.93	-49.05	-	-
Net Income	-52.29	-175.77	-548.98	-245.39	-241.34
Net Income to Common	-52.29	-175.77	-548.98	-245.39	-241.34
Shares Outstanding (Basic)	27	24	10	3	-
Shares Outstanding (Diluted)	27	24	10	3	-
Shares Change (YoY)	10.61%	137.49%	212.57%	-	-
EPS (Basic)	-1.94	-7.23	-53.63	-74.93	-
EPS (Diluted)	-1.94	-7.23	-53.63	-74.93	-
Free Cash Flow	-33.99	-185.4	-326.31	-199.83	-117.22
Free Cash Flow Per Share	-1.26	-7.63	-31.88	-61.02	-
Gross Margin	63.66%	42.71%	-10.58%	-7.82%	13.16%
Operating Margin	-7.03%	-81.62%	-194.12%	-210.25%	-124.04%
Profit Margin	-17.12%	-86.77%	-233.91%	-115.64%	-134.59%
Free Cash Flow Margin	-11.13%	-91.52%	-139.04%	-94.17%	-65.37%
EBITDA	-0.41	-138.21	-439.67	-429.94	-213.69
EBITDA Margin	-0.13%	-68.23%	-187.34%	-202.62%	-119.17%
D&A For EBITDA	21.05	27.13	15.91	16.21	8.73
EBIT	-21.46	-165.34	-455.58	-446.15	-222.42
EBIT Margin	-7.03%	-81.62%	-194.12%	-210.25%	-124.04%
Revenue as Reported	305.45	202.57	234.69	212.2	179.32

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q